Publications | Veröffentlichungen

Journals | Zeitschriften (peer reviewed)

• Schuhmacher, Alexander; Exploring open source as a strategy to enhance R&D productivity; in: Expert Opinion on Drug Discovery; S. 1 - 4; 10/2024;
• Schuhmacher, Alexander; Gassmann, Oliver; Hinder, Markus; Hartl, Dominik; Comparative analysis of FDA approvals by top 20 pharma companies (2014–2023); in: Drug Discovery Today; S. 1 - 8; 09/2024;
• Schuhmacher, Alexander; Hinder, Markus; Boger, Nikolaj; Gassmann, Oliver; Hartl, Dominik; Is the blockbuster imperative broken?; in: Drug Discovery Today; S. 1 - 4; 11/2023;
• Schuhmacher, Alexander; Hinder, Markus; Dodel, Alexander; Gassmann, Oliver; Hartl, Dominik; Investigating the origins of recent pharmaceutical innovation; in: Nature Reviews Drug Discovery; S. 781 - 782; 10/2023;
• Schuhmacher, Alexander; Hinder, Markus; von Stegmann und Stein, Alexander; Hartl, Dominik; Gassmann, Oliver; Analysis of pharma R&D productivity – a new perspective needed; in: Drug Discovery Today; S. 1 - 8; 10/2023;
• Schuhmacher, Alexander; Hinder, Markus; Boger, Nikolaj; Hartl, Dominik; Gassmann, Oliver; The significance of blockbusters in the pharmaceutical industry; in: Nature Reviews Drug Discovery; S. 1 - 5; 12/2022;
• Schuhmacher, Alexander; Häfner, Naomi; Honsberg, Katharina; Goldhahn, Jörg; Gassmann, Oliver; The dominant logic of Big Tech in healthcare and pharma; in: Drug Discovery Today; S. 1 - 10; 11/2022;
• Schuhmacher, Alexander; Gassmann, Oliver; Bieniok, Doria; Hinder, Markus; Hartl, Dominik; Open innovation: A paradigm shift in pharma R&D?; in: Drug Discovery Today; S. 2395 - 2405; 09/2022;
• Schuhmacher, Alexander; Brieke, Clara; Gassmann, Oliver; Hinder, Markus; Hartl, Dominik; Systematic risk identification and assessment using a new risk map in pharmaceutical R&D; in: Drug Discovery Today; S. 2786 - 2793; 12/2021;
• Schuhmacher, Alexander; Gatto, Alexander; Kuss, Michael; Gassmann, Oliver; Hinder, Markus; Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence; in: Drug Discovery Today; S. 2226 - 2231; 10/2021;
• Schuhmacher, Alexander; Wilisch, Lukas; Kuss, Michael; Kandlbauer, Andreas; Hinder, Markus; Gassmann, Oliver; R&D efficiency of leading pharmaceutical companies - A 20-year analysis; in: Drug Discovery Today; S. 1784 - 1789; 08/2021;
• Hartl, Dominik; de Luca, Valeria; Kostikova, Anna; Laramie, Jason; Kennedy, Scott; Ferrero, Enrico; Siegel, Richard; Fink, Martin; Ahmed, Sohail; Millholland, John; Schuhmacher, Alexander; Hinder, Markus; Piali, Luca; Roth, Adrian; Translational precision medicine: an industry perspective; in: Journal of Translational Medicine; S. 245 - 258; 06/2021;
• Schuhmacher, Alexander; Gassmann, Oliver; Hinder, Markus; Kuss, Michael; The present and future of project management in pharmaceutical R&D; in: Drug Discovery Today; S. 1 - 4; 01/2021;
• Schuhmacher, Alexander; Gatto, Alexander; Hinder, Markus; Kuss, Michael; Gassmann, Oliver; The upside of being a digital pharma player; in: Drug Discovery Today; S. 1569 - 1574; 09/2020;
• Schuhmacher, Alexander; Kuss, Michael; The impact of crowdsourcing in modern drug discovery; in: Expert Opinion Drug Discovery; S. 865 - 867; 08/2020;
• Schuhmacher, Alexander; Gassmann, Oliver; Kuss, Michael; Hinder, Markus; The Art of Virtualizing Pharma R&D; in: Drug Discovery Today; S. 2105 - 2107; 11/2019;
• Schuhmacher, Alexander; Gassmann, Oliver; McCracken, Nigel; Hinder, Markus; Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?; in: Journal of Translational Medicine; S. 119 - 132; 05/2018;
• Schuhmacher, Alexander; Gassmann, Oliver; Hinder, Markus; Changing R&D models in research-based pharmaceutical companies; in: Journal of Translational Medicine; S. 105 - 115; 04/2016;

Books | Fachbücher (peer/editorial reviewed)

• Hinder, Markus; Schuhmacher, Alexander; Goldhahn, Jörg; Hartl, Dominik; Principles of Biomedical Science and Industries; 1. Auflage; Wiley-VCH; 07/2022;
• Gassmann, Oliver; Schuhmacher, Alexander; von Zedtwitz, Max; Reepmeyer, Gerrit; Leading Pharmaceutical Innovation; 3. Auflage; Springer Nature; 06/2018;
• Schuhmacher, Alexander; Hinder, Markus; Gassmann, Oliver; Value Creation in the Pharmaceutical Industry; 1. Auflage; Wiley-VCH; 01/2016;

Other activities | Sonstige Aktivitäten

Stand: 21.11.2024 05:00:12